PSAT1 and central nervous system cancer: In our results, the expression levels of PSAT1 were also significantly higher in grade II and III gliomas with IDH1 mutations than in those of IDH1 wild-type (Figure 4A), and significantly higher in grade II gliomas than in grade III gliomas (Figure 4B).